Professor of Neuropharmacology, University of Central Lancashire
Colin Davidson is a neuropharmacologist and neurochemist. His main current interest is in drug abuse, and he has recently studied a number of legal highs. He is particularly interested in their pharmacology and their effects on transmitter release. Previously he has tested novel pharmacotherapies for stimulant abuse. He has also published in the field of Stroke where he has an interest in pre-ischaemic conditioning. His PhD was in the field of antidepressants and 5-HT efflux.
US drugs regulator gives LSD ‘breakthrough’ status for treating anxiety – why this is so significant
Apr 26, 2024 01:29 am UTC| Insights & Views Business Health
LSD was accidentally discovered by Albert Hofmann at the Sandoz pharmaceutical company in Switzerland in 1938. It was apparently useless, but from 1947 it was marketed as a cure for everything from schizophrenia to...
A brief history of drug-fuelled combatants
Jan 04, 2024 04:36 am UTC| Health
My friend Luke used to drink a pint of beer before a game of rugby. I dont know whether he thought that it might reduce pain or improve performance, but the idea of taking drugs before going into battle goes back to the...
Dopamine menus: the science behind the trend – and how it might help people with ADHD
Dec 12, 2023 16:00 pm UTC| Health
Menus are usually something youd expect to come across in a restaurant. But one social media influencer went viral recently for sharing a different kind of menu a dopamine menu or dopamenu. The dopamine menu concept...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects